Genetic analysis of essential hypertension in Japanese populations

Annals of the New York Academy of Sciences

Volumn 902, Issue , 2000, Pages 8-16

  Ogihara, Toshio ^a   Katsuya, Tomohiro ^a   Higaki, Jitsuo ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE; RENIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; CASE CONTROL STUDY; CONFERENCE PAPER; CONTROLLED STUDY; DNA POLYMORPHISM; ESSENTIAL HYPERTENSION; GENE LOCUS; GENETIC ANALYSIS; GENETIC PREDISPOSITION; HEALTH STATUS; HUMAN; JAPAN; MAJOR CLINICAL STUDY; NONHUMAN; PATHOGENESIS; POPULATION RESEARCH; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SAMPLING;

ANIMALIA;

EID: 0034130675     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06296.x     Document Type: Conference Paper

References (25)

1. 1. PICKERING, G. 1978. Normotension and hypertension: the mysterious viability of the false. Am. J. Med. 65: 561-563.
2. 2. KIM, H.S. et al. 1995. Genetic control of blood pressure and the angiotensinogen locus. Proc. Natl. Acad. Sci. USA 92: 2735-2739.
3. 3. KATSUYA, T. et al. 1991. Substrain comparison of genetically hypertensive rats using DNA fingerprinting, and genetic analysis of blood pressure in the inbred rats. Tohoku J. Exp. Med. 165: 253-260.
4. 4. KATSUYA, T. et al. 1993. A neuropeptide Y locus on chromosome 4 cosegregates with blood pressure in the spontaneously hypertensive rat. Biochem. Biophys. Res. Commun. 192: 261-267.
5. 5. TAKAMI, S. et al. 1996. Analysis and comparison of new candidate loci for hypertension between genetic hypertensive rat strains. Hypertens. Res. 19: 51-56.
6. 6. KATSUYA, T. et al. 1992. Hypotensive effect associated with a phospholipase C-delta 1 gene mutation in the spontaneously hypertensive rat. Biochem. Biophys. Res. Commun. 187: 1359-1366.
7. 7. WALKER, W.G. et al. 1979. Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects. Hypertension 1: 287-291.
8. 8. JEUNEMAITRE, X. et al. 1992. Molecular basis of human hypertension: role of angiotensinogen. Cell 71: 169-180.
9. 9. KATSUYA, T. et al. 1995. Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet 345: 1600-1603.
10. 10. CAMBIEN, F. et al. 1992. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359: 641-644.
11. 11. YOSHIDA, H. et al. 1995. Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J. Clin. Invest. 96: 2162-2169.
12. 12. MARRE, M. et al. 1994. Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 43: 384-388.
13. 13. O'DONNELL, C.J. et al. 1998. Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation 97: 1766-1772.
14. 14. FORNAGE, M. et al. 1998. Variation in the region of the angiotensin-converting enzyme gene influences interindividual differences in blood pressure levels in young white males. Circulation 97: 1773-1779.
15. 15. CAMBIEN, F. 1994. The angiotensin-converting enzyme (ACE) genetic polymorphism: its relationship with plasma ACE level and myocardial infarction. Clin. Genet. 46: 94-101.
16. 16. BONNARDEAUX, A. et al. 1994. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 24: 63-69.
17. 17. BENETOS, A. et al. 1995. Influence of angiotensin II type 1 receptor polymorphism on aortic stiffness in never-treated hypertensive patients. Hypertension 26: 44-47.
18. 18. KATSUYA, T. et al. 1997. Genomic organization and polymorphism of human angiotensin II type 2 receptor: No evidence for its gene mutation in two families of human premature ovarian failure syndrome. Mol. Cell. Endocrinol. 127: 221-228.
19. 19. MANNAMI, T., et al. 1997. Prevalence of asymptomatic carotid atherosclerotic lesions detected by high-resolution ultrasonography and its relation to cardiovascular risk factors in the general population of a Japanese city, the Suita study. Stroke 28: 518-525.
20. 20. KALININA, O. et al. 1997. Nanoliter scale PCR with TaqMan detection. Nucleic Acids Res. 25: 1999-2004.
21. 21. KUNZ, R. et al. 1997. Association between the angiotensinogen 235T-variant and essential hypertension in whites: a systematic review and methodological appraisal. Hypertension 30: 1331-1337.
22. 22. JACOB, H.J. et al. 1991. Genetic mapping of a gene causing hypertension in the stroke-prone spontaneously hypertensive rat. Cell 67: 213-224.
23. 23. AGERHOLM LARSEN, B. et al. 1997. ACE gene polymorphism: ischemic heart disease and longevity in 10,150 individuals. A case-referent and retrospective cohort study based on the Copenhagen City Heart Study. Circulation 95: 2358-2367.
24. 24. KRUSHKAL, J. et al. 1999. Genome-wide linkage analyses of systolic blood pressure using highly discordant siblings. Circulation 99: 1407-1410.
25. 25. HUNT, S.C. et al. 1998. Angiotensinogen genotype, sodium reduction, weight loss and prevention of hypertension - Trials of Hypertension Prevention, Phase II. Hypertension 32: 393-401.